Delivery Order SPE2DR25D3016-SPE2DR26FG2LR
- Not listed
- The Defense Logistics Agency awarded a $11,504.60 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of PHESGO 600-600 MG pharmaceutical product in 20,000 units of 10ML vials, with performance concluding by December 29, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $17,256.90 to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of PHESGO 600-600 MG pharmaceutical product in 10ML units (20,000 units total). This is a firm fixed-price delivery order with an ultimate completion date of December 29, 2025, and represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $5,458.39 to AmerisourceBergen Drug Corp for 20,000 units of PHESGO 600-600 mg in 10ml vials, with a completion deadline of September 16, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $23,009.20 delivery order to AmerisourceBergen Drug Corp for PHESGO 600-600 MG pharmaceutical products (20,000 units of 10ML vials). This is a firm fixed price, non-competitive delivery order with an ultimate completion date of December 9, 2025, to be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The Defense Logistics Agency awarded a Delivery Order valued at $11,504.60 to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of PHESGO 600-600 MG pharmaceutical product in 20,000-unit quantities of 10 mL vials. The contract utilizes firm fixed pricing with no set-aside designation, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 7, 2026. This delivery...
- The Defense Logistics Agency awarded a $5,458.39 delivery order to AmerisourceBergen Drug Corp for 20,000 units of PHESGO 600-600 MG in 10ML vials. This delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, operates under a firm fixed-price contract type with no set-aside designation. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order valued at $32,750.34 to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of PHESGO 600-600 mg pharmaceutical product in 20,000 units of 10ml vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 26, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was...
- The Defense Logistics Agency awarded a delivery order valued at $11,504.60 to AmerisourceBergen Drug Corp for the supply of PHESGO 600-600 MG pharmaceutical product, consisting of 20,000 units of 10ML vials. This competitively awarded, non-set-aside contract features firm fixed pricing and is scheduled for completion by December 9, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,916.78 to AmerisourceBergen Drug Corp for PHESGO 600-600 mg pharmaceutical products (20,000 units of 10ml vials). This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The award was made on September 25, 2025, with an ultimate completion date of October 17, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of...
- The Defense Logistics Agency awarded a $21,833.56 firm fixed price delivery order to AmerisourceBergen Drug Corp for PHESGO 600-600 mg pharmaceutical products (20,000 units of 10ml vials), with an ultimate completion date of November 10, 2025. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in...
- SPE2DR25D3016Indefinite Delivery Contract
- SPE2DR25D3016-SPE2DR26FG2LRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for 20,000 units of PHESGO 600-600 MG in 10ML vials, valued at $17,256.90. This competitively awarded, firm fixed-price delivery order is scheduled for completion by January 13, 2026, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order leverages the company's existing pharmaceutical supply infrastructure to support federal medical procurement needs. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for the Defense Logistics Agency's Medical Supply Chain, holding a substantial Indefinite Delivery Contract (SPE2DX) valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current delivery order for PHESGO, a specialty pharmaceutical product, exemplifies the company's role in fulfilling specialized medical supply requirements across the federal healthcare system, including support for the Defense Health Agency and other government medical programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.3k | 12/18/25 |